Navigation Links
Amgen Initiates Voluntary Nationwide Recall of Certain Lots of EPOGEN® and PROCRIT® (Epoetin alfa)
Date:9/24/2010

hysician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.  Adverse events that may be related to the use of this product may also be reported to the United States Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting Program either online, by regular mail or by fax:


  • Online: www.fda.gov/medwatch/report.htm
  • Regular Mail: use postage-paid FDA form 3500 available at:
    www.fda.gov/MedWatch/getforms.htm.
    Mail to MedWatch, FDA, 5600 Fishers Lane, Rockville, MD 20852-9787
  • Fax: 1-800-FDA-0178
  • Amgen and Centocor Ortho Biotech Products and their affiliate companies have initiated recall letters and other communication to immediately inform relevant stakeholders, including healthcare professionals, distributors, wholesalers and pharmacies of the voluntary recall.  The letters include instructions to return the referenced product to the returned goods service provider.

    The recall is being conducted in cooperation with the United States Food and Drug Administration.

    EPOGEN and PROCRIT are manufactured in the United States by Amgen. EPOGEN is sold by Amgen in the United States.  Centocor Ortho Biotech Products is the authorized distributor of PROCRIT in the United States.

    About EPOGEN (Epoetin alfa)EPOGEN is indicated for the treatment of anemia in patients with chronic renal failure on dialysis. EPOGEN is indicated to elevate or maintain the red blood cell (RBC) level and to decrease the need for transfusions in these patients.

    About PROCRIT (Epoetin alfa) PROCRIT is used for the treatment of anemia in patients with most types of cancer receiving chemotherapy, with chronic renal failure who are on dialysis and those who are not on
    '/>"/>

    SOURCE Amgen
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

    Related medicine technology :

    1. Arthritis Foundation Announces Amgen and Wyeth to Be Presenting Sponsor of the 2008 Arthritis Walk (R)
    2. Medarex to Receive Milestone Payment from Amgen
    3. AMT Obtains License to Amgens GDNF Gene to Develop Treatment for Parkinsons Disease with AMTs Proprietary Gene Therapy Platform
    4. Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer
    5. CDC Foundation Partners with Amgen, CDC to Reduce Infections Among Cancer Patients
    6. Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)
    7. Amgen Issues Statement on Outcomes of Advisory Committee for Reproductive Health Drugs (ACRHD) Meeting
    8. Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes
    9. Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP
    10. Amgen Highlights Data to be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting
    11. Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/6/2015)... , July 6, 2015 Hologic, Inc. ... plans to release its financial results for the third ... after the market closes.  In conjunction with the release, ... 4:30 p.m. Eastern Time. Interested participants may ... the United States ) or 719-325-4804 (for ...
    (Date:7/6/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/58tdl6/pharmaceutical ) ... Sodium Chloride Market by Applications, by Region - Industry ... offering. The pharmaceutical grade sodium chloride market ... 2014 and 2019 in terms of volume, and the ... The report on Pharmaceutical grade sodium chloride ...
    (Date:7/6/2015)... July 6, 2015 Array BioPharma,s (NASDAQ: ... this past weekend at the 2015 ESMO World ... At the meeting, data were shared from a ... 100-patient randomized Phase 2 expansion of that trial ... EGFR inhibitor, with or without the addition of ...
    Breaking Medicine Technology:Hologic to Announce Financial Results for the Third Quarter of Fiscal 2015 on Wednesday, July 29, 2015 2Global Pharmaceutical Grade Sodium Chloride Market Report 2015 2Global Pharmaceutical Grade Sodium Chloride Market Report 2015 3Encorafenib-Based Regimens Show Promising Clinical Activity In BRAF-Mutant Colorectal Cancer Patients 2Encorafenib-Based Regimens Show Promising Clinical Activity In BRAF-Mutant Colorectal Cancer Patients 3Encorafenib-Based Regimens Show Promising Clinical Activity In BRAF-Mutant Colorectal Cancer Patients 4
    ... , ORLANDO, Fla. , May 19 ... of medicine to their daily routine.  In 2009, drug trend ... increased 10.8 percent, driven by a 5 percent increase in ... 2010 Drug Trend Report.  The growth in prescription drug use ...
    ... May 19 Five presentations reporting the ... LYSTEDA™ (tranexamic acid) tablets, a novel, first-in-class, non-hormonal therapy ... bleeding (HMB), were presented at The American College of ... San Francisco , May 15-19, 2010 .  It ...
    Cached Medicine Technology:New Research: Kids' Consumption of Chronic Medications on the Rise 2New Research: Kids' Consumption of Chronic Medications on the Rise 3New Research: Kids' Consumption of Chronic Medications on the Rise 4New Research: Kids' Consumption of Chronic Medications on the Rise 5Clinical Data Demonstrates That LYSTEDA™ Significantly Reduced Menstrual Blood Loss and Limitations on Social, Leisure and Physical Activities in Women With Cyclic HMB 2Clinical Data Demonstrates That LYSTEDA™ Significantly Reduced Menstrual Blood Loss and Limitations on Social, Leisure and Physical Activities in Women With Cyclic HMB 3Clinical Data Demonstrates That LYSTEDA™ Significantly Reduced Menstrual Blood Loss and Limitations on Social, Leisure and Physical Activities in Women With Cyclic HMB 4Clinical Data Demonstrates That LYSTEDA™ Significantly Reduced Menstrual Blood Loss and Limitations on Social, Leisure and Physical Activities in Women With Cyclic HMB 5Clinical Data Demonstrates That LYSTEDA™ Significantly Reduced Menstrual Blood Loss and Limitations on Social, Leisure and Physical Activities in Women With Cyclic HMB 6
    (Date:7/6/2015)... (PRWEB) , ... July 06, 2015 , ... University ... revising national guidelines for thyroid cancer testing to reflect newly available tests that better ... to use and how to interpret thyroid cancer tests is published in the July ...
    (Date:7/6/2015)... ... 2015 , ... Shortly after opening her second practice in Signal Hill, Dr. ... on a lien basis. Dr. Lim had previously worked with Dr. Kevin Kelly, ... refugees, Dr. Lim suffered with back pain herself throughout high school. Unaware of ...
    (Date:7/6/2015)... Beach, Virginia (PRWEB) , ... July 06, 2015 ... ... States choose fat-reduction procedures each year for aesthetic reasons, which is why liposuction ... country. For a particular demographic, however, fat reduction has become more than a ...
    (Date:7/6/2015)... Columbus, OH (PRWEB) , ... July 06, 2015 ... ... obtaining the proper reimbursement for radiology services and ADVOCATE is leading the transition. ... leveraging their coding expertise with their Top 10 Tips for ICD-10. The ten ...
    (Date:7/6/2015)... Chester, NJ (PRWEB) , ... July 06, 2015 ... ... CancerHopeNetwork.org. The redesigned site allows newly-diagnosed cancer patients, caregivers and medical professionals to ... who has survived the same cancer. , “Receiving a cancer diagnosis is often ...
    Breaking Medicine News(10 mins):Health News:Pitt Scientists Lead Consensus Guidelines for Thyroid Cancer Molecular Tests 2Health News:Pitt Scientists Lead Consensus Guidelines for Thyroid Cancer Molecular Tests 3Health News:Pitt Scientists Lead Consensus Guidelines for Thyroid Cancer Molecular Tests 4Health News:Pitt Scientists Lead Consensus Guidelines for Thyroid Cancer Molecular Tests 5Health News:Respected Chiropractor Opens Office in Signal Hill/Cambodia Town and Joins Doctors on Liens 2Health News:Learn How CoolSculpting® and Liposuction in Virginia Beach Help Military Members Stay the Course 2Health News:Learn How CoolSculpting® and Liposuction in Virginia Beach Help Military Members Stay the Course 3Health News:ADVOCATE Takes the Lead to Ensure ICD-10 Success: “Top 10 Tips for ICD-10” 2Health News:Cancer Hope Network Launches Upgraded Website to Support Cancer Patients, Caregivers 2
    ... blood boil in anger, but as a new study has found, ... attack. ,Researchers base their findings on more than 8,000 ... ,As a part of the Whitehall Study II, the civil ... often have the feeling that I am being treated unfairly" on ...
    ... chronic obstructive pulmonary disease among men has discovered that ... inflammatory lung disease (COPD). ,COPD (chronic obstructive ... lung disease, such as emphysema and bronchitis. ... men, who were already part of the US Health ...
    ... American inventor has come out with a machine that ... working at the computer. ,The researchers from ... "walk-and-work" desk, suggest it could help overweight workers shed ... The workstation can be locked in place over a ...
    ... flu vaccines to healthy adults in the age range of 5 ... . The U.S Food and Drug Administration is now ... 5 years. ,This announcement comes at a time when ... 15.6 billion dollars. AstraZeneca was behind MedImmune because it did ...
    ... to increase the risk of heart attacks and death in patients ... is caused by plaque build-up on the inside walls of the ... causes them to harden and narrow. This in addition, ... complications. , According to a report in the Journal ...
    ... advanced than expected about 29 millions years ago, a new ... ,Elwyn Simons identified the second and the most intact ... it to micro CT scanning to calculate the approximate dimensions ... on previous fossils collected at the same dig site in ...
    Cached Medicine News:Health News:Heart Attack Risk Increased by Unfair Treatment 2Health News:Stand Up And Get Back To Work! 2Health News:Influenza Vaccine FluMist To Be Approved In Younger Children As Well 2Health News:Dont Worry- Be Good To Your Heart 2
    ... A necessary addition to ... the Reichert Trial Frame ... and smooth controls for ... robust design, high-quality materials, ...
    ... The Ultramatic Rx Master is ... years of reliable service and ... that measurably improve procedures. It ... need and want most, including ...
    The Maverick Over-The-Wire balloon catheter delivers a new level of performance to meet the changing demands of interventional cardiology....
    ... Illumination is provided by a cool-running, energy ... only what you need to see without ... of all they are maintenance free so ... bulb. Every Phoroptor comes with a limited ...
    Medicine Products: